Glymidine sodium (INN also known as glycodiazine; trade name Gondafon) is a sulfonamide antidiabetic drug structurally related to the sulfonylureas. It was first reported in 1964 and introduced to clinical use in Europe in the mid to late 1960s.
This page contains content from the copyrighted Wikipedia article "Glymidine sodium"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.